Form: CORRESP

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

September 29, 2017

 


 

 https:||www.sec.gov|Archives|edgar|data|882291|000101968716006211|logo.jpg

9635 Granite Ridge Drive

Suite 100

San Diego, CA 92123

Phone 858-459-7800

 

September 29, 2017

 

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, D.C. 20549

 

Attention:  

Russell Mancuso, Esq.

Heather Percival, Esq.

 

Re:  

Aethlon Medical, Inc.

Registration Statement on Form S-1

File No. 333-219589

REQUEST FOR ACCELERATION OF EFFECTIVENESS

 

Dear Mr. Mancuso and Ms. Percival:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Aethlon Medical, Inc. (the “Registrant”) hereby respectfully requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-219589), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern Daylight Time on September 29, 2017, or as soon as practicable thereafter.

 

The Registrant hereby authorizes Jolie Kahn, Esq., to orally modify or withdraw this request for acceleration.

 

We respectfully request that we be notified of such effectiveness by a telephone call to Ms.Kahn at (516) 217-6379.

 

    Very truly yours,
     
    AETHLON MEDICAL, INC.
     
     
     
    /s/ James B. Frakes
    James B. Frakes
    Chief Financial Officer